Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Metastatic NUT Carcinoma × etoposide phosphate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 2 Small Cell Lung Carcinoma 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Metastatic NUT Carcinoma 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Myeloid, Acute 1

Interventions

molibresib 1 etoposide phosphate 1 Platinum 1 Etoposide 1 Cisplatin 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04116359 2020-09-28

Testing of the Addition of a New Anti-cancer Drug, Molibresib, to Chemotherapy Treatment (Etoposide and Cisplatin) for Patients With NUT Carcinoma

National Cancer Institute (NCI)

Phase 1/2 Withdrawn

Metastatic NUT Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡